Recombinant Human VEGFB Protein（HEK293），GST

Vascular endothelial growth factor B (VEGFB) is a member of the VEGF family, primarily known for its role in angiogenesis and maintaining vascular homeostasis. Unlike other VEGF isoforms, VEGFB primarily acts on lymphatic endothelium and is crucial for the development and survival of endothelial cells. Recent studies have highlighted its involvement in various physiological processes, including lipid metabolism, neuroprotection, and cardiac function. Research has shown that VEGFB can promote the survival of damaged neurons and enhance cardiac repair following ischemic injury, suggesting its potential therapeutic implications for cardiovascular and neurodegenerative diseases. Given its significant role in these biological processes, the recombinant protein form of VEGFB is being investigated for its potential applications in drug development and regenerative medicine. Scientists are particularly interested in characterizing VEGFB's structure-function relationships to explore its mechanism of action, optimize its therapeutic properties, and assess its efficacy in preclinical models. Furthermore, understanding the interaction between VEGFB and its receptors could unveil new pathways for treatment strategies aimed at diseases characterized by inadequate blood supply or impaired tissue repair. Overall, the study of VEGFB recombinant proteins has garnered attention due to their promise in enhancing tissue regeneration and their ability to modulate vascular responses, making them a focal point in contemporary biomedical research.